Facebook Linkedin Twitter
Inside Precision Medicine A Pill for That: Biora’s Innovative Pills Aim to Optimize Drug Delivery

Ulcerative colitis

Biora Therapeutics
News & Features

A Pill for That: Biora’s Innovative Pills Aim to Optimize Drug Delivery

Jonathan D. Grinstein, PhD
0
Diseased colon, illustration
News & Features

AbbVie Pumps up Autoimmune Portfolio by Acquiring Landos

0
IBD, Crohn's disease, ulcerative colitis
News & Features

Thanksgiving Turkey Could Ease Ulcerative Colitis Symptoms

0
IBD, Crohn's disease, ulcerative colitis
Molecular Dx

Measurable Markers in Blood Can Be Detected Up to Eight Years Before IBD Diagnosis

0
IBD, Crohn's disease, ulcerative colitis
News & Features

Sanofi and Teva Ink Deal Worth Potentially $1.5B for Anti-TL1A IBD Candidate

0
Ulcerative Colitis Pains
Molecular Dx

AGA Releases Guidelines on Use of Fecal and Blood Tests for Monitoring Ulcerative Colitis

0
IBD, Crohn's disease, ulcerative colitis
News & Features

Prometheus’ $500M Public Offering to Fund Phase III UC, Crohn’s Studies

0
Young male in stream of digital information
News & Features

Twinning is Winning

Chris Anderson
0
IBD, Crohn's disease, ulcerative colitis
News & Features

10 New Genetic Variants of Crohn’s Disease Susceptibility Uncovered

0
Johnson & Johnson’s Janssen Research & Development will use BiomX's XMarker platform to discover microbiome-based biomarkers for inflammatory bowel disease (IBD)
News & Features

New IBD, Colorectal Tumor Treatment Target Found

0
12Page 1 of 2

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine